All In Biotech

Free tool

FAERS Monitor: Tamiflu

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021246 or its brand name (Tamiflu, Oseltamivir Phosphate). Reports on generic versions are filed under their own applications.

Reports

18,140

Serious

11,193

62% of reports

Hospitalization

4,480

Death reported

1,814

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vomiting1,886
  • nausea1,364
  • no adverse event1,058
  • influenza963
  • abnormal behaviour927
  • diarrhoea867
  • dyspnoea863
  • hallucination827
  • pyrexia746
  • headache678
  • drug ineffective648
  • pneumonia644
  • off label use618
  • rash610
  • cough600

Reports by year received

View as table
YearReports
2004153
2005393
2006278
2007546
2008351
20091,569
20101,311
2011477
2012518
2013550
2014475
20151,361
20161,136
20171,867
20181,599
20191,157
20201,013
2021405
2022380
2023525
20241,174
2025556
2026345

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,019 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
abnormal behaviourSignal92727.826.023,370
hallucinationSignal82712.912.08,961
influenzaSignal96310.19.57,852
no adverse eventSignal1,0586.86.45,247
vomitingSignal1,8864.74.55,530
pyrexiaSignal7462.52.3682
coughSignal6002.52.3536
pneumoniaSignal6442.32.1483
nausea1,3642.01.9706
dyspnoea8631.81.7295
rash6101.61.5148
diarrhoea8671.61.5178
headache6781.31.236
off label use6180.80.826
drug ineffective6480.60.5224

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.